|
BCL2L11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.036340E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.407500E-04 |
| Normal-vs-Stage2 |
6.996200E-03 |
| Normal-vs-Stage3 |
3.972400E-04 |
| Normal-vs-Stage4 |
1.061840E-03 |
| Stage1-vs-Stage2 |
6.593400E-01 |
| Stage1-vs-Stage3 |
3.207200E-01 |
| Stage1-vs-Stage4 |
3.392200E-01 |
| Stage2-vs-Stage3 |
7.894800E-01 |
| Stage2-vs-Stage4 |
7.560600E-01 |
| Stage3-vs-Stage4 |
9.351800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.245690E-04 |
| Normal-vs-AfricanAmerican |
3.963900E-03 |
| Normal-vs-Asian |
4.661800E-01 |
| Caucasian-vs-AfricanAmerican |
5.950400E-01 |
| Caucasian-vs-Asian |
5.490200E-01 |
| AfricanAmerican-vs-Asian |
4.770000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.375670E-03 |
| Normal-vs-Female |
1.59455999999558E-05 |
| Male-vs-Female |
2.746100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.606300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.198700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.89445999999593E-05 |
| Normal-vs-Age(81-100Yrs) |
4.103300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.329000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.157200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.822600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.682400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.422200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.251600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.470800E-01 |
| Normal-vs-Grade 2 |
8.622600E-03 |
| Normal-vs-Grade 3 |
2.11379999999206E-05 |
| Normal-vs-Grade 4 |
4.238800E-04 |
| Grade 1-vs-Grade 2 |
9.470200E-01 |
| Grade 1-vs-Grade 3 |
3.809400E-01 |
| Grade 1-vs-Grade 4 |
3.669000E-01 |
| Grade 2-vs-Grade 3 |
2.676000E-02 |
| Grade 2-vs-Grade 4 |
7.476100E-02 |
| Grade 3-vs-Grade 4 |
8.200200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.245900E-04 |
| Normal-vs-ccB subtype |
4.055000E-03 |
| ccA subtype-vs-ccB subtype |
5.710400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.576500E-04 |
| Normal-vs-N1 |
1.106430E-01 |
| N0-vs-N1 |
9.177200E-01 |
|
|
